ATE382048T1 - Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen - Google Patents

Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen

Info

Publication number
ATE382048T1
ATE382048T1 AT03752559T AT03752559T ATE382048T1 AT E382048 T1 ATE382048 T1 AT E382048T1 AT 03752559 T AT03752559 T AT 03752559T AT 03752559 T AT03752559 T AT 03752559T AT E382048 T1 ATE382048 T1 AT E382048T1
Authority
AT
Austria
Prior art keywords
pyrazolopyrimdines
inhibitors
cyclin dependent
dependent kinases
kinases
Prior art date
Application number
AT03752559T
Other languages
English (en)
Inventor
Michael Dwyer
Timothy Guzi
Kamil Paruch
Ronald Doll
Kartik Keertikar
Viyyoor Girijavallabhan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE382048T1 publication Critical patent/ATE382048T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03752559T 2002-09-19 2003-09-17 Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen ATE382048T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41213802P 2002-09-19 2002-09-19

Publications (1)

Publication Number Publication Date
ATE382048T1 true ATE382048T1 (de) 2008-01-15

Family

ID=32030811

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03752559T ATE382048T1 (de) 2002-09-19 2003-09-17 Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen

Country Status (19)

Country Link
US (1) US7151104B2 (de)
EP (1) EP1539750B1 (de)
JP (1) JP4845380B2 (de)
KR (1) KR20050072090A (de)
CN (1) CN100475812C (de)
AR (1) AR041292A1 (de)
AT (1) ATE382048T1 (de)
AU (1) AU2003270846B2 (de)
CA (1) CA2499593C (de)
DE (1) DE60318321T2 (de)
ES (1) ES2297203T3 (de)
HK (1) HK1071758A1 (de)
IL (1) IL167432A (de)
MX (1) MXPA05003059A (de)
MY (1) MY136840A (de)
NZ (1) NZ538595A (de)
TW (1) TWI283243B (de)
WO (1) WO2004026872A1 (de)
ZA (1) ZA200502271B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0977563B1 (de) * 1996-12-03 2005-10-12 Sloan-Kettering Institute For Cancer Research Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
ATE450534T1 (de) 2002-08-23 2009-12-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte davon, analoga und ihre verwendung
AU2005276231A1 (en) * 2004-08-27 2006-03-02 Cyclacel Limited Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
ME01222B (me) * 2005-02-28 2013-06-20 Eisai R&D Man Co Ltd Nova kombinovana upotreba jedinjenja sulfonamida u liječenju kancera
JP5106098B2 (ja) * 2005-02-28 2012-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド化合物の抗癌剤との新規併用
US7304074B2 (en) 2005-04-05 2007-12-04 Hoffmann-La Roche Inc. Substituted 1,5-naphthyridine azolinones
US7417053B2 (en) 2005-04-07 2008-08-26 Teijin Pharma Limited Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
KR20080002935A (ko) * 2005-04-07 2008-01-04 데이진 화-마 가부시키가이샤 피라졸로［1,5-ａ］피리딘 유도체 또는 그 의학상 허용되는염
JP2009507843A (ja) 2005-09-09 2009-02-26 シェーリング コーポレイション アザ縮合サイクリン依存性キナーゼ阻害剤
MX2009005478A (es) * 2006-11-27 2009-08-12 Lundbeck & Co As H Derivados de heteroarilamida.
KR20090031122A (ko) * 2007-09-21 2009-03-25 주식회사 중외제약 인다졸 골격을 함유하는 화합물, 이의 제조방법 및 상기화합물을 함유하는 약제학적 조성물
FR2940284B1 (fr) * 2008-12-19 2011-02-18 Sanofi Aventis Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
JP6861166B2 (ja) * 2015-03-27 2021-04-21 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド サイクリン依存性キナーゼの阻害剤
CN108700594B (zh) 2015-11-18 2021-06-29 建新公司 多囊性肾病的生物标志物及其用途
MX2019002616A (es) * 2016-09-07 2019-09-18 Shanghai Haihe Pharmaceutical Co Ltd Compuesto de anillo aromatico de pirido de cinco elementos, metodo de preparacion y uso del mismo.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1066147C (zh) 1995-11-01 2001-05-23 诺瓦提斯公司 嘌呤衍生物及其制备方法
ES2281941T3 (es) 1997-12-13 2007-10-01 Bristol-Myers Squibb Company Uso de pirazolo(3,4-b)piridina como inhibidores de quinasa dependiente de ciclina.
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
FR2801308B1 (fr) * 1999-11-19 2003-05-09 Oreal COMPOSITIONS DE TEINTURE DE FIBRES KERATINIQUES CONTENANT DE DES 3-AMINO PYRAZOLO-[1,(-a]-PYRIDINES, PROCEDE DE TEINTURE, NOUVELLES 3-AMINO PYRAZOLO-[1,5-a]-PYRIDINES
CN100356979C (zh) * 2000-02-03 2007-12-26 卫材R&D管理有限公司 整联蛋白表达抑制剂
JP2004516297A (ja) 2000-12-20 2004-06-03 ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・（エス．セー．エール．アー．エス） サイクリン依存性キナーゼ（ｃｄｋ）及びグリコーゲンシンターゼキナーゼ−３（ｇｓｋ−３）の阻害剤
BR0207762A (pt) * 2001-03-08 2004-06-01 Astrazeneca Ab Uso de um composto ou um sal farmaceuticamente aceitável do mesmo, combinação, formulação farmacêutica, kit, método para a prevenção da úlcera gástrica induzida por medicamento, e, composição farmacêutica oral
CN1202896C (zh) * 2002-02-07 2005-05-25 北京燕化高新技术股份有限公司 空气分离时纯化空气的方法

Also Published As

Publication number Publication date
TWI283243B (en) 2007-07-01
AU2003270846B2 (en) 2006-11-23
JP4845380B2 (ja) 2011-12-28
NZ538595A (en) 2006-04-28
DE60318321T2 (de) 2008-12-11
AU2003270846A1 (en) 2004-04-08
DE60318321D1 (en) 2008-02-07
ZA200502271B (en) 2005-09-19
ES2297203T3 (es) 2008-05-01
KR20050072090A (ko) 2005-07-08
HK1071758A1 (en) 2005-07-29
MXPA05003059A (es) 2005-05-27
CA2499593C (en) 2011-08-16
AR041292A1 (es) 2005-05-11
CN100475812C (zh) 2009-04-08
CA2499593A1 (en) 2004-04-01
US7151104B2 (en) 2006-12-19
EP1539750A1 (de) 2005-06-15
EP1539750B1 (de) 2007-12-26
MY136840A (en) 2008-11-28
CN1681816A (zh) 2005-10-12
IL167432A (en) 2010-05-17
US20040097516A1 (en) 2004-05-20
JP2006503060A (ja) 2006-01-26
WO2004026872A1 (en) 2004-04-01
TW200409775A (en) 2004-06-16

Similar Documents

Publication Publication Date Title
NO20045220L (no) Heterocykliske inhibitorer for kinaser
DE602004008303D1 (de) Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3
ATE452891T1 (de) Pyrimidopyrimidone als kinaseinhibitoren
NO20050636L (no) Inhibitorer av tyrosinkinaser
ATE378336T1 (de) Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
DE60321808D1 (de) Flavon derivate als inhibitoren von cyclin-abhängigen kinasen
ATE382048T1 (de) Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen
ATE369356T1 (de) Pyridazinon-derivate als cdk2-hemmer
DE60313872D1 (de) Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
ATE378337T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE404564T1 (de) Diazepinoindolderivate als kinaseinhibitoren
ATE374201T1 (de) 6-alkoxypyridopyrimidine als inhibitoren der p-38-map-kinase
PL377825A1 (pl) Diaminotriazole użyteczne jako inhibitory kinaz białkowych
ATE455546T1 (de) Aminotriazol-verbindungen als proteinkinase- hemmer
HK1072545A1 (en) Novel inhibitors of kinases
ATE443706T1 (de) Pyrrolotriazinverbindungen als kinaseinhibitoren
ATE364608T1 (de) Pyrazolopyrimidine als hemmstoffe cyclin- abhängiger kinasen
ATE376548T1 (de) Pyrazolopyrimidine als hemmstoffe cyclin- abhängiger kinasen
ATE411306T1 (de) Biarylsulfonamide als mmp-inhibitoren
DK1811998T3 (da) Triazoler anvendelige som inhibitorer af proteinkinaser
DE602004026905D1 (de) 2-aminoaryloxazol-verbindungen als tyrosinkinase-hemmer
DE60328233D1 (de) Sulfamatbenzothiophenderivate als steroidsulfataseinhibitoren
ZA200700751B (en) Azalndoles useful as inhibitors of protein kinases
IS7963A (is) Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa
ATE520399T1 (de) Aminoindazole derivate als kinase inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties